| Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer (NCT00733850) | KangLaiTe USA | 2008-08-01 |
| AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01) (NCT00638612) | Candel Therapeutics, Inc. | 2008-08-01 |
| IDO Inhibitor Study for Relapsed or Refractory Solid Tumors (NCT00739609) | NewLink Genetics Corporation | 2008-08-01 |
| APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer (NCT00709826) | Tragara Pharmaceuticals, Inc. | 2008-08-01 |
| Efavirenz as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer (NCT00964171) | Institut Bergonié | 2008-08-01 |
| BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC") (NCT03311776) | Inna Chen, MD | 2008-07-03 |
| Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery (NCT00727441) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-07-02 |
| Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI) (NCT00920023) | Massachusetts General Hospital | 2008-07-01 |
| Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer (NCT00902733) | City of Hope Medical Center | 2008-07-01 |
| Phase I/II Trial of Radiation, Avastin and Tarceva for Pancreatic Adenocarcinoma (NCT00735306) | Duke University | 2008-07-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic Cancer (NCT00556023) | AstraZeneca | 2008-06-01 |
| Abraxane Therapy in Patients With Pancreatic Cancer Who Failed First-Line Gemcitabine Therapy (NCT00691054) | University of Miami | 2008-06-01 |
| A Biomarker Identification Trial of Tarceva (Erlotinib) in Patients With Advanced Pancreatic Cancer (NCT00674973) | Hoffmann-La Roche | 2008-06-01 |
| A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor Response (NCT01209962) | University of Michigan Rogel Cancer Center | 2008-05-01 |
| Human Leukocyte Antigen-A*2402-Restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer (NCT00683358) | Tokyo University | 2008-05-01 |
| Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00703638) | Masonic Cancer Center, University of Minnesota | 2008-05-01 |
| Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer (NCT00683085) | Tokyo University | 2008-05-01 |
| A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT00652366) | Hoffmann-La Roche | 2008-05-01 |
| Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer (NCT00885066) | Centre Antoine Lacassagne | 2008-05-01 |
| Monoclonal Antibody RAV12 and Gemcitabine in Treating Patients With Metastatic Pancreatic Cancer (NCT00625586) | MacroGenics | 2008-04-15 |
| HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) (NCT01266720) | Fukushima Medical University | 2008-04-01 |
| Pancreatic Stent to Prevent Leak After Distal Pancreatectomy (NCT00671463) | Massachusetts General Hospital | 2008-04-01 |
| First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer (NCT00673504) | Central European Society for Anticancer Drug Research | 2008-04-01 |
| Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer (NCT00640978) | M.D. Anderson Cancer Center | 2008-03-01 |
| Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer (NCT00660348) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-03-01 |
| NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma (NCT00667082) | Celgene | 2008-03-01 |
| Proton Therapy for Unresectable Cancer (CA) of Pancreas (NCT00685763) | University of Florida | 2008-03-01 |
| Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer (NCT00967603) | IRCCS San Raffaele | 2008-02-01 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00757614) | Cancer Research UK | 2008-02-01 |
| Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers (NCT00626158) | University of California, San Francisco | 2008-02-01 |
| Gemcitabine With or Without Capecitabine and/or Radiation Therapy or Gemcitabine With or Without Erlotinib in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery (NCT00634725) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2008-02-01 |
| GI-4000 With Adoptive Transfer in Pancreatic Cancer (NCT00837135) | University of Pennsylvania | 2008-01-01 |
| Oxaliplatin, Gemcitabine, and Erlotinib Study in Patients With Advanced Chemo-naïve Pancreatic Cancer (NCT00636883) | National Guard Health Affairs | 2008-01-01 |
| Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer (NCT00614653) | M.D. Anderson Cancer Center | 2008-01-01 |
| Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes (NCT01033695) | Odense University Hospital | 2008-01-01 |
| Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer (NCT00603863) | Gilead Sciences | 2008-01-01 |
| Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer (NCT00826982) | Mayo Clinic | 2008-01-01 |
| Low Dose Vaccine Study for Surgically Resected Pancreatic Cancer (NCT00614601) | NewLink Genetics Corporation | 2008-01-01 |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms (NCT01640522) | University of Pittsburgh | 2008-01-01 |
| Pancreatic Cancer Genetics (NCT01102569) | Columbia University | 2008-01-01 |
| An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer (NCT00570713) | Morphotek | 2007-12-01 |
| Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer (NCT00565487) | Milton S. Hershey Medical Center | 2007-12-01 |
| Vaccine Study for Surgically Resected Pancreatic Cancer (NCT00569387) | NewLink Genetics Corporation | 2007-12-01 |
| Neoadjuvant Accelerated Short Course Radiation Therapy With Proton Beam and Capecitabine for Resectable Pancreatic Cancer (NCT00438256) | Massachusetts General Hospital | 2007-12-01 |
| Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma (NCT00789763) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2007-12-01 |
| Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking (NCT00666978) | Lisa Sanderson Cox, PhD | 2007-12-01 |
| CC-4047 With Gemcitabine for Untreated Advanced Carcinoma of the Pancreas (NCT00540579) | SCRI Development Innovations, LLC | 2007-11-01 |
| An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs (NCT00414570) | AHS Cancer Control Alberta | 2007-11-01 |
| Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer (NCT00568646) | CASI pharmaceuticals, Inc. | 2007-11-01 |
| Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer (NCT00898781) | Mayo Clinic | 2007-11-01 |
| A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer (NCT00553813) | Cortice Biosciences, Inc. | 2007-10-01 |
| Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors (NCT00551096) | University of Colorado, Denver | 2007-10-01 |
| Chemotherapy With or Without Dalteparin in Treating Patients With Metastatic Pancreatic Cancer (NCT00662688) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2007-10-01 |
| Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery (NCT00536874) | Memorial Sloan Kettering Cancer Center | 2007-10-01 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer (NCT00553683) | Rutgers, The State University of New Jersey | 2007-10-01 |
| Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer (NCT00548626) | University of Chicago | 2007-10-01 |
| Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer (NCT00529113) | Biogen | 2007-09-30 |
| Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer (NCT00547612) | National Institutes of Health Clinical Center (CC) | 2007-09-01 |
| Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine (NCT00550004) | SciClone Pharmaceuticals | 2007-09-01 |
| A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer (NCT00536770) | Novacea | 2007-09-01 |
| Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (Phase1/2) (NCT00655785) | Fukushima Medical University | 2007-09-01 |
| Study of Gemcitabine and Erlotinib Plus Sorafenib (GES) in Metastatic Pancreatic Cancer (NCT00696696) | NYU Langone Health | 2007-09-01 |
| Dasatinib in Treating Patients With Stage IV Pancreatic Cancer (NCT00544908) | City of Hope Medical Center | 2007-09-01 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) and Pancreatic Function Following Surgery (NCT01094535) | Columbia University | 2007-09-01 |
| A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies (NCT00529984) | AlphaVax, Inc. | 2007-09-01 |
| Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer (NCT01662609) | H. Lee Moffitt Cancer Center and Research Institute | 2007-08-23 |
| Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer (NCT00521404) | Daiichi Sankyo | 2007-08-15 |
| A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer (NCT00642733) | Hoffmann-La Roche | 2007-08-01 |
| Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors (NCT00609765) | H. Lee Moffitt Cancer Center and Research Institute | 2007-08-01 |
| Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers (NCT00684801) | Case Comprehensive Cancer Center | 2007-08-01 |
| Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery (NCT00900016) | Fox Chase Cancer Center | 2007-08-01 |
| Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (NCT01212887) | Cancer Research UK | 2007-08-01 |
| Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic Cancer (NCT00498225) | Taiho Pharmaceutical Co., Ltd. | 2007-07-01 |
| Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer (NCT00504998) | Epeius Biotechnologies | 2007-07-01 |
| AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic Cancer (NCT00493441) | Vertex Pharmaceuticals Incorporated | 2007-06-01 |
| Huachansu & Gemcitabine in Pancreatic Cancer (NCT00837239) | M.D. Anderson Cancer Center | 2007-06-01 |
| AS703569 and Gemcitabine Combination in Advanced Malignancies (NCT01097512) | Merck KGaA, Darmstadt, Germany | 2007-06-01 |
| GEM vs GEM+TS-1 for Advanced Pancreatic Cancer (NCT00514163) | Japan Clinical Cancer Research Organization | 2007-06-01 |
| QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer (NCT00630552) | NantCell, Inc. | 2007-06-01 |
| A Study of Tarceva (Erlotinib) in Combination With Gemcitabine in Unresectable and/or Metastatic Cancer of the Pancreas: Relationship Between Skin Toxicity and Survival (NCT00461708) | Hoffmann-La Roche | 2007-05-01 |
| Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic Cancer (NCT00851955) | Mayo Clinic | 2007-05-01 |
| Studying Biomarkers in Patients With Pancreatic Cancer (NCT00900003) | Vanderbilt-Ingram Cancer Center | 2007-05-01 |
| Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer. (NCT00364364) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-05-01 |
| Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery (NCT00599833) | The Christie NHS Foundation Trust | 2007-05-01 |
| A Single-Patient Study Using AGS 006 (NCT00664482) | Argos Therapeutics | 2007-05-01 |
| Clinical Trial of Pancreatic Cancer in Stockholm. (NCT02162823) | Karolinska University Hospital | 2007-05-01 |
| Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract (NCT00511264) | Odense University Hospital | 2007-05-01 |
| A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors (NCT00465725) | Poniard Pharmaceuticals | 2007-04-01 |
| Endoscopic Drainage of Collections After Pancreatic Surgery (NCT02909296) | Institut Paoli-Calmettes | 2007-04-01 |
| Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery (NCT01248663) | Medical University of Vienna | 2007-04-01 |
| Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00499265) | Heidelberg Pharma AG | 2007-04-01 |
| Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer (NCT00456599) | University of Michigan Rogel Cancer Center | 2007-04-01 |
| Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer (NCT00602602) | Abramson Cancer Center at Penn Medicine | 2007-03-01 |
| Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer (NCT00639925) | Fukushima Medical University | 2007-03-01 |
| Endoscopic Ultrasound-guided Celiac Plexus Neurolysis (EUS-CPN)With Alcohol in Unresectable Pancreatic Cancer: a Pilot Study (NCT00578279) | Indiana University | 2007-03-01 |
| Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors (NCT00620295) | Masonic Cancer Center, University of Minnesota | 2007-03-01 |
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors (NCT00667641) | University of Medicine and Dentistry of New Jersey | 2007-03-01 |
| Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers (NCT01445327) | National Cancer Institute (NCI) | 2007-02-20 |